CAS: 1361227-90-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | JH-RE-06 REF: TM-T15611CAS: 1361227-90-8 | 99.29% | 46,00 €~1.076,00 € | Mar 07 Ene 25 |
 | JH-RE-06 REF: 3D-LEC22790CAS: 1361227-90-8 | Min. 95% | A consultar | Mar 18 Feb 25 |
JH-RE-06
CAS:1361227-90-8
JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ.
Fórmula:
C20H16Cl3N3O4
Pureza:
99.29%
Forma y color:
Solid
Peso molecular:
468.72
Ref: TM-T15611
| 1mg | 46,00 € | ||
| 5mg | 96,00 € | ||
| 10mg | 157,00 € | ||
| 25mg | 346,00 € | ||
| 50mg | 606,00 € | ||
| 100mg | 1.076,00 € | ||
| 1mL*10mM (DMSO) | 89,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
JH-RE-06
CAS:1361227-90-8
JH-RE-06 is a drug that can be used to treat cancer. It is an inhibitor …
Fórmula:
C20H16Cl3N3O4
Pureza:
Min. 95%
Peso molecular:
468.72 g/mol
Ref: 3D-LEC22790
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
